Better understanding of blood flow means better treatment for patients.
In 1960, magnetic resonance imaging (MRI) characterized flow velocities of sea water with a precision of 10-8 centimeters per second(1). When applied to human blood, flow-sensitive MRI can detect a variety of flow properties characteristic of pathological change.
Flow-sensitive MRI protocols have recently evolved from “2D phase contrast” to “4D flow.” 2D phase contrast had the capability to characterize through-plane or in-plane flow measurements, secondary to one-way velocity encoding. 4D flow, however, can characterize flow properties within a 3D volumetric region, secondary to three-way velocity encoding. 4D flow images can be interrogated with a posteriori analyses and yield detailed information, such as vorticity(2), wall shear stress (WSS)(3), and turbulent kinetic energy(4).
Through applying 4D flow imaging, interventional radiologists may be able to improve the efficacy of their neurovascular, lymphatic, and hepatic interventions.
Pathology related to the neuro-vasculature often presents in high acuity settings. It would be valuable if aneurysm rupture or progression could be predicted by 4D flow-derived measurements, such as WSS. Several studies have already shown that correlations exist between intra-aneurysmal flow and WSS with aneurysm characteristics.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
Arteriovenous malformations (AVMs) represent another opportunity for pre-intervention imaging. It has been suggested that quantitative 4D flow can identify AVM tributary arteries with the highest flow rates. This may enable more successful targeted-embolization treatment of AVMs, prior to surgical resection(5).
4D flow also has potential application, after neurovascular interventions. Flow-diverter stents are currently used to treat sidewall intracranial aneurysms. Despite low velocities within these stents, a flow change index (proportional velocity reduction ratio) was contrived(6). Indices, such as this imply potential for the clinical implementation of 4D flow MRI in post-procedure monitoring, despite metallic stents and low-flow properties in this setting.
Properties of lymph fluid (few cells, clear fluid) and the lymph system itself (variable presence of fluid within vessels) present challenges for visualization. Although procedures, such as thoracic duct and intrahepatic lymphatic duct embolization have been reported, imaging challenges limit the role of the interventionalist in patients with lymphatic disorders.
Lymphatic vessels lie deep, below superficial lymphatic networks, and actively contract via unknown mechanisms. Because 4D flow can quantify flow patterns in volumetric regions of interest, it may hold value in better understanding the interrelatedness of venous, arterial, and lymphatic flows as they relate to disease. Several animal studies have investigated ways that lymph flow relates to tissue pressures(7,8). Dynamic 4D contrast-enhanced magnetic resonance lymphangiography has been shown to demonstrate the time course of contrast agent flow up the central lymphatic ducts(9) and doppler optical coherence tomography has been shown to depict lymph velocity at high temporal resolution(10). 4D flow may enhance our understanding (and visualization) of the lymphatic system.
Portal blood flow has also been studied with 4D flow MRI. Flow volumes were shown to significantly increase in the superior mesenteric vein and portal vein (PV) after transjugular intrahepatic portosystemic shunt (TIPS) placement. In this same cohort, flow differences were seen in the TIPS to PV flow ratio between the six patients with resolved ascites at two and 12 weeks after TIPS (0.8 and 0.9, respectively) and the one patient with refractory ascites (4.6 and 4.2, respectively)(11). Patency and stenosis evaluation following TIPS placement(12)and following PV stent placement(13) represent additional opportunities for 4D flow analysis of the portal vasculature.
In conclusion, 4D flow MRI provides clinicians with advanced quantifiable measures of blood flow. Although the technology is in its early stages, and more applications are being realized, post- and pre- intervention 4D flow acquisitions appear capable of providing clinicians with valuable insight. Pre-procedural 4D flow MRI may improve understanding (and disease screening) in the vascular and lymphatic systems. Post-procedural monitoring similarly appears to be a useful application of 4D flow MRI, especially in the neuro- and portal- vasculature.
According to Charles Dotter, M.D., “If a plumber can do it to pipes, we can do it to blood vessels”. Rerouting and restoring blood flow is the concept behind much of an interventional radiologist’s work. Delicate blood vessels, however, are not steel pipes. If we can better understand blood flow, we can better treat patients. Instead of simply sea(ing) water move, we can now “sea” blood move. Let’s make the most of this remarkable ability and continue to push interventional radiology forward.
Follow Editorial Board member Jack Cerne, M.D., on Twitter @JackCerne.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
The Reading Room Podcast: Emerging Trends in the Radiology Workforce
February 11th 2022Richard Duszak, MD, and Mina Makary, MD, discuss a number of issues, ranging from demographic trends and NPRPs to physician burnout and medical student recruitment, that figure to impact the radiology workforce now and in the near future.
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.